NASDAQ:ADROAduro BioTech Earnings Date, Estimates & History

$2.70

+0.21 (+8.43 %)

(As of 04/8/2020 04:00 PM ET)

Add

Compare

Today's Range

$2.49

Now: $2.70▼

$2.71

50-Day Range

$2.01

MA: $2.89▼

$3.87

52-Week Range

$0.90

Now: $2.70▼

$4.59

Volume291,683 shs

Average Volume1.19 million shs

Market Capitalization$218.05 million

P/E RatioN/A

Dividend YieldN/A

Beta0.32

Aduro BioTech (NASDAQ:ADRO) Earnings Information

Aduro BioTech last announced its quarterly earnings results on March 9th, 2020. The biotechnology company reported ($0.24) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.21) by $0.03. The firm had revenue of $3.63 million for the quarter, compared to analyst estimates of $4.95 million. Aduro BioTech has generated ($1.03) earnings per share over the last year. Aduro BioTech has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 5th, 2020 based off prior year's report dates.

Aduro BioTech Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Aduro BioTech (NASDAQ:ADRO) Earnings Estimates

2020 EPS Consensus Estimate: ($0.85)
2021 EPS Consensus Estimate: ($0.64)

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2020	2	($0.23)	($0.09)	($0.16)
Q2 2020	2	($0.24)	($0.19)	($0.22)
Q3 2020	2	($0.29)	($0.20)	($0.25)
Q4 2020	2	($0.26)	($0.20)	($0.23)
Q1 2021	1	($0.16)	($0.16)	($0.16)
Q2 2021	1	($0.16)	($0.16)	($0.16)
Q3 2021	1	($0.16)	($0.16)	($0.16)
Q4 2021	1	($0.16)	($0.16)	($0.16)

Aduro BioTech (NASDAQ ADRO) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Reported EPS	GAAP EPS	Revenue Estimate	Actual Revenue	Conference Call
5/5/2020 (Estimated)
3/9/2020	12/31/2019	($0.21)	($0.24)	($0.24)	$4.95 million	$3.63 million	N/A
11/7/2019	Q3	($0.2320)	($0.20)	($0.26)	$4.55 million	$4.80 million	N/A
8/1/2019	Q2 2019	($0.18)	($0.23)	($0.23)	$4.56 million	$4.89 million	N/A
5/7/2019	Q1	($0.19)	($0.29)	($0.29)	$8.08 million	$3.94 million	N/A
2/27/2019	Q4 2018	($0.23)	($0.28)	($0.23)	$5.98 million	$2.76 million	N/A
10/30/2018	9/30/2018	($0.31)	($0.29)	($0.29)	$4.59 million	$3.06 million	N/A
8/1/2018	Q2 2018	($0.33)	($0.31)	($0.31)	$3.74 million	$2.64 million	N/A
5/2/2018	Q1 2018	($0.35)	($0.2760)	($0.28)	$3.88 million	$6.63 million	N/A
3/1/2018	Q4 2017	($0.36)	($0.35)	($0.36)	$4.32 million	$3.76 million	N/A
10/31/2017	Q3 2017	($0.30)	($0.33)	($0.33)	$4.04 million	$3.79 million	N/A
8/3/2017	Q2 2017	($0.25)	($0.27)	($0.27)	$3.98 million	$5.90 million	N/A
5/2/2017	Q1 2017	($0.3880)	($0.32)	($0.32)	$3.74 million	$3.77 million	N/A
3/1/2017	Q4 2016	($0.40)	($0.4390)	($0.44)	$3.83 million	$3.88 million	N/A
11/2/2016	Q3 2016	($0.45)	($0.54)	($0.54)	$3.99 million	$3.79 million	N/A
8/3/2016	Q2 2016	($0.18)	$0.03	$0.03	$25.24 million	$39.00 million	N/A
5/2/2016	Q116	($0.25)	($0.45)	($0.45)	$13.47 million	$4.03 million	N/A
3/8/2016	Q415	($0.15)	$0.04	$0.04	$17.55 million	$34.38 million	N/A
11/23/2015	Q3	($0.08)	$0.01	$0.01	$15.80 million	$19.15 million	N/A
8/10/2015	Q215	($0.01)	($0.18)	$0.14	$1.00 million	$9.90 million	N/A
5/28/2015	Q115	($0.08)	($39.97)	($39.97)	$12.03 million	$9.60 million	N/A

(Earnings results data provided by Zacks Investment Research)

This page was last updated on 4/8/2020 by MarketBeat.com Staff

Featured Article: What are the disadvantages of after-hours trading?

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

NASDAQ:ADROAduro BioTech Earnings Date, Estimates & History

Adding

Adding

Adding Aduro BioTech Inc

Earnings

Aduro BioTech (NASDAQ:ADRO) Earnings Information

Aduro BioTech Earnings Estimates and Actuals by Quarter

Aduro BioTech (NASDAQ:ADRO) Earnings Estimates

Aduro BioTech (NASDAQ ADRO) Earnings History by Quarter

Start Your Free Trial Today

Market Data and Calendars

Investing Education and Resources